Moertel CL - Search Results

1

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.

Ogino H, Taylor JW, Nejo T, Gibson D, Watchmaker PB, Okada K, Saijo A, Tedesco MR, Shai A, Wong CM, Rabbitt JE, Olin MR, Moertel CL, Nishioka Y, Salazar AM, Molinaro AM, Phillips JJ, Butowski NA, Clarke JL, Oberheim Bush NA, Hervey-Jumper SL, Theodosopoulos P, Chang SM, Berger MS, Okada H. Ogino H, et al. Among authors: moertel cl. J Clin Invest. 2022 Feb 1;132(3):e151239. doi: 10.1172/JCI151239. J Clin Invest. 2022. PMID: 34882581 Free PMC article. Clinical Trial.

2

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.

Olin MR, Low W, McKenna DH, Haines SJ, Dahlheimer T, Nascene D, Gustafson MP, Dietz AB, Clark HB, Chen W, Blazar B, Ohlfest JR, Moertel C. Olin MR, et al. J Immunother Cancer. 2014 Feb 18;2:4. doi: 10.1186/2051-1426-2-4. eCollection 2014. J Immunother Cancer. 2014. PMID: 24829761 Free PMC article.

3

Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.

Olin MR, Pluhar GE, Andersen BM, Shaver R, Waldron NN, Moertel CL. Olin MR, et al. Among authors: moertel cl. Crit Rev Immunol. 2014;34(5):399-432. doi: 10.1615/critrevimmunol.2014011577. Crit Rev Immunol. 2014. PMID: 25404047 Free PMC article. Review.

4

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.

Moertel CL, Xia J, LaRue R, Waldron NN, Andersen BM, Prins RM, Okada H, Donson AM, Foreman NK, Hunt MA, Pennell CA, Olin MR. Moertel CL, et al. J Immunother Cancer. 2014 Dec 16;2(1):46. doi: 10.1186/s40425-014-0046-9. eCollection 2014. J Immunother Cancer. 2014. PMID: 25598973 Free PMC article.

5

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Xiong Z, Ampudia-Mesias E, Shaver R, Horbinski CM, Moertel CL, Olin MR. Xiong Z, et al. Among authors: moertel cl. Immunotherapy. 2016 Sep;8(9):1059-71. doi: 10.2217/imt-2016-0033. Immunotherapy. 2016. PMID: 27485078 Free PMC article.

6

Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.

Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA, Pluhar GE. Olin MR, et al. Among authors: moertel cl. Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137. Cancers (Basel). 2019. PMID: 30682795 Free PMC article.

7

CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy.

Xiong Z, Ampudia Mesias E, Pluhar GE, Rathe SK, Largaespada DA, Sham YY, Moertel CL, Olin MR. Xiong Z, et al. Among authors: moertel cl. Clin Cancer Res. 2020 Jan 1;26(1):232-241. doi: 10.1158/1078-0432.CCR-19-2234. Epub 2019 Oct 17. Clin Cancer Res. 2020. PMID: 31624103

8

CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR. Ampudia-Mesias E, et al. Among authors: moertel cl. Neurotherapeutics. 2021 Jul;18(3):1980-1994. doi: 10.1007/s13311-021-01038-1. Epub 2021 Apr 7. Neurotherapeutics. 2021. PMID: 33829411 Free PMC article.

9

CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors.

Moertel C, Martinez-Puerta F, Pluhar GGE, Castro MG, Olin M. Moertel C, et al. Expert Opin Investig Drugs. 2022 Sep;31(9):875-879. doi: 10.1080/13543784.2022.2108588. Epub 2022 Aug 3. Expert Opin Investig Drugs. 2022. PMID: 35920338 Free PMC article. No abstract available.

10

Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR. Ampudia-Mesias E, et al. Among authors: moertel cl. Neurotherapeutics. 2021 Jul;18(3):2131. doi: 10.1007/s13311-021-01062-1. Neurotherapeutics. 2021. PMID: 33929711 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page